Strong growth beat, margin pressure concerns amid capex investment
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Buy
confidence 8/10
Grade A
Beat prior 20% FY27 guidance (31.7% YoY). EBITDA margin 11.6% met 11%+ target. PAT margin guidance (5.5-6%) conservative vs Q2 delivery.
Optimistic
next 1–2 quarters
Very Optimistic
multi-year
Strong structural tailwinds in transmission and distribution (₹9.15L Cr opportunity till '32) backed by ₹14.2 Cr order book and capacity roadmap deliver 31.7% YoY growth. However, QoQ PAT -3.7% despite +18.4% revenue signals margin compression from elevated depreciation/interest as capex ramps; near-term guidance maintained but realization hinges on execution and cost inflation containment.
₹2056.3 Cr
Revenue · +31.7% YoY₹103.9 Cr
Reported PAT · +14.2% YoYCompressing
Margins · vs guidance: CorroboratedDid the claims hold up?
Q2 revenue INR2,056 Cr, 32% YoY growth
METDelivered ₹2,056.3 Cr, 31.7% YoY growth
EBITDA margin 11.6%, PAT 104 Cr up 12% YoY
METDelivered NPM 5.0%, PAT ₹103.9 Cr up 14.2% YoY
20% growth for next 3 years
METQ2 delivered 31.7% YoY, well above guidance; prior 20% FY27 target exceeded
11% plus EBITDA margin maintained
METQ2 delivered 11.5% OPM; guidance reaffirmed, on track
PAT margin 5.5-6% going forward
OVERSTATEDQ2 delivered 5.0% NPM; QoQ PAT -3.7% signals margin headwinds
Earnings quality
What changed since the last call
Order book +27% since Q1
UpgradeQ1 Q2 end order book ₹14.2K Cr vs ₹11.2K Cr inferred Q1 (from disclosure of INR1.747 Cr post-quarter orders = 15.95K Cr prospective). Large order additions visible in 5-conductor HTLS jobs (₹770 Cr) and solver project (₹400-500 MW).
Capacity roadmap accelerated
UpgradeTower capacity 1.84L → 2L tons by end FY27 (vs ₹200 Cr capex announced prior). Conductor 40.8K → 49.5K km. Re-conductoring HTLS entry (₹770 Cr awarded; margin uplift potential).
Margin pressure acknowledged vs prior confidence
DowngradePAT margin Q2 5.0% vs Q1 est. 5.4% (implied from H1 ₹212 Cr PAT / ₹3,792 Cr H1 revenue). Depreciation +35%, interest rising. Guidance to 5.5-6% effectively caps upside; not a cut but reality check.
Solar diversification advanced
New49% stake in 990 MW solar project (Maharashtra), INR3.9K Cr capex. IPP adjacent to core T&D; CFO guided revenue entry FY28. Not prior guidance; new strategic lever.
The Q&A
Analysts (Yash Kabra, Balamurali Krishna, Anurag) pressed hard on margin anomaly: revenue +32%, EBITDA +28%, PAT +12% (vs Q2 actual +14%). CFO Rajesh held firm on 11%+ EBITDA, 5.5-6% PAT guidance; attributed delta to depreciation/interest/tax rate. No concessions on near-term guidance but acknowledged capex headwinds. Tone cautious but credible.
Capacity utilization & peak revenue — Harshit, RoboCapital
AnsweredRandeep: INR12,000 Cr feasible by FY29; 20% growth minimum for next 3 yrs based on current order book and execution pace. Staggered 24-30m project cycle enables phased ramp.
Margin trajectory with capacity — Yash Kabra, Nirmal Bang
AnsweredCFO Rajesh: Interest marginally up on absolute basis but declining to revenue %. Depreciation +35% YoY from capex acceleration. Tax was one-off 25-26% normalizing; going forward PAT margin 5.5-6%. All embedded in order book quality.
HTLS re-conductoring opportunity — Deepak Purswani, SVAN Investments
AnsweredRandeep: Both product and EPC. Epsilon (French) supplying carbon core; margin in line with current strategy (margin enabler + cash flow enabler). Plant fungible across product categories.
Export mix and pricing — Sahil Patani, Stokes Capital
AnsweredRandeep: 60% domestic, 40% intl target. Hedging on commodity (aluminum for conductors); margin profile Q2 level maintained. Intl high-tariff/multinational funding drives margin selectivity.
Solar IPP financials & timeline — Balamurali Krishna, Oman Investment
PartialCFO Rajesh: ~INR500 Cr equity, balance debt (already closed). Recurring revenue; fixed tariff. CFO noted adjacent business for leverage. Revenue FY28 onwards.
BESS & data center progress — Rahul, HL Technology
PartialRandeep: Work in progress; teams being built. QIP content not finalized; 6+ months out. Expected outcome this financial year.
Order intake guidance confidence — Anurag, Indira Securities
AnsweredRandeep: Full confidence. INR10,000-odd crore order intake with 10-12% win ratio on INR30K+ Cr bidding pipeline. Backward integration (own towers/conductors) provides execution edge.
Receivables management — Balamurali Krishna
AnsweredCFO Deepak: Increase noted but focus to reduce in ensuing quarter. 82-day WC cycle maintained overall.
Product diversification timing — Balamurali Krishna
AnsweredRandeep: 2-5% product, 5-7% intent (not committed). Core T&D 85-90% stable. New products incremental, not dilutive.
Guidance
FY27 20% YoY growth maintained
HighQ2 delivered 31.7% YoY; prior guidance 20%. On track. No numeric revision.
INR10,000+ Cr annual order intake target
HighAlready INR3.5K Cr in H1; bidding pipeline INR30K+ Cr with 10-12% historical win ratio. Order book ₹14.2K Cr supports.
INR12,000 Cr revenue by FY29 feasible
MediumImplies ~20% CAGR from FY27 base. Contingent on capacity ramp, order execution, and new verticals (solar IPP, HTLS, exports) ramping on schedule.
EBITDA 11%+ maintained
HighQ2 delivered 11.6%. Cost inflation (depreciation +35%, interest rising) offset by operational leverage and capex completion benefits.
PAT margin 5.5-6% going forward
MediumQ2 5.0%, Q1 est. 5.4%. Depreciation and interest pressuring. Tax normalized from one-off 25-26%. Range acknowledges near-term headwinds but suggests recovery as capex matures.
INR3.9K Cr solar IPP capex; ~INR500 Cr equity, balance debt
HighAlready financed. Phased: 400-500 MW expected ~March '28. Recurring fixed-tariff revenue post-completion.
Core T&D capex on course; tower +200K tons, conductor +40.8K km cumulative
HighPhase 1 completed ahead of schedule. Further expansion under evaluation pending market demand and internal cash accruals.
Risks the call surfaced
Margin compression
HighDepreciation +35% YoY and interest costs rising on absolute basis eroding PAT margin from 5.4% (Q1 est.) to 5.0% (Q2). Capex cycle will sustain pressure until facilities fully amortized.
Capex execution risk
MediumTower capacity roadmap to 2L tons and conductor to 49.5K km by end FY27. Solar IPP ₹3.9K Cr capex with FY28 revenue entry. Any slippage delays order conversion and revenue recognition.
Order book concentration
MediumOrder book ₹14.2K Cr disclosed, but customer/segment mix not granularly disclosed. Large transmission/distribution projects may be concentrated with 2-3 anchor customers; loss of key customer or project delay could dent revenue.
Solar IPP execution & monetization
MediumSolar IPP (49% stake) ₹3.9K Cr capex. Revenue entry guided FY28 onwards (March 28 or later). Any project delays, PPA settlement issues, or capacity under-utilization would defer material revenue.
International market traction
LowGreenfield GIS project (Jordan), seed orders in US/Australia, international export mix targeted 40% by next 2-3y. Early-stage with pricing/margin unknown; execution risk and competitive intensity in international EPC could dent margins vs domestic.
Management
Score 8/10. Clear on numbers and strategy. Transparent on challenges (margin pressure, depreciation, capex timing). Granular on order book, capacity roadmap, and new initiatives. Some hedging on solar IPP details (CFO: 'after 6, 12 months we can answer') but not evasive. Capacity expansion Phase 1 completed ahead of schedule. Revenue guidance 20% FY27 beat (31.7% YoY Q2). Order book tracking strongly (₹14.2K Cr visible). EBITDA 11.6% sustained vs 11%+ target. PAT margins under pressure but acknowledged by management with credible root causes (depreciation, interest, tax normalization).
1 · Q3-Q4 FY27
Order book execution; tower/conductor capacity fully commissioned (2L/49.5K km)
2 · FY28
Solar IPP revenue launch (≥400-500 MW approx); re-conductoring jobs ramp
3 · H2 FY27
Greenfield GIS Jordan project (400kV/765kV lines); US/intl export traction
However, QoQ PAT -3.7% despite +18.4% revenue signals margin compression from elevated depreciation/interest as capex ramps; near-term guidance maintained but realization hinges on execution and cost inflation containment.
Informational and educational content only. Not investment advice.